145 related articles for article (PubMed ID: 2531058)
21. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
Szegedi G
Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
[TBL] [Abstract][Full Text] [Related]
23. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
[TBL] [Abstract][Full Text] [Related]
24. [A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)].
Usova SB; Sigidin IaA
Ter Arkh; 1993; 65(5):65-9. PubMed ID: 8036601
[TBL] [Abstract][Full Text] [Related]
25. [Cyclosporin in autoimmune diseases].
Follath F; Fontana A; Leumann E; Michel BA; Miescher PA; Schreier M; Schroeder M; Wenk M
Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1232-9. PubMed ID: 8052828
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
28. Interim report of clinical studies presented at the International Symposium on Ciclosporin in Auto-Immune Diseases, Basel, March 18-20, 1985.
Schmitz-Schumann M
Prog Allergy; 1986; 38():436-46. PubMed ID: 3755240
[No Abstract] [Full Text] [Related]
29. [Immunomodulating therapy of rheumatoid arthritis].
Balabanova RM; Barakat B
Revmatologiia (Mosk); 1990; (3):38-44. PubMed ID: 2151541
[No Abstract] [Full Text] [Related]
30. [Cyclosporin-A therapy in autoimmune diseases].
Patakfalvi A
Orv Hetil; 1996 Sep; 137(35):1921-7. PubMed ID: 8927346
[TBL] [Abstract][Full Text] [Related]
31. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
Tarr T; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2005 Dec; 146(49):2485-9. PubMed ID: 16398313
[TBL] [Abstract][Full Text] [Related]
32. Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy.
Ferraccioli G; Falleti E; De Vita S; Di Poi E; Damato R; Casatta L; Salaffi F
J Rheumatol; 1998 Oct; 25(10):1874-9. PubMed ID: 9779838
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
[TBL] [Abstract][Full Text] [Related]
34. Leflunomide-associated pancytopenia with or without methotrexate.
Chan J; Sanders DC; Du L; Pillans PI
Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
[TBL] [Abstract][Full Text] [Related]
35. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
36. [Systemic autoimmune diseases].
Kawai S; Takagi K; Kusunoki Y; Nishio S; Matsumoto N
Nihon Rinsho; 2008 Jan; 66(1):130-6. PubMed ID: 18193552
[TBL] [Abstract][Full Text] [Related]
37. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
Looney RJ
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
[TBL] [Abstract][Full Text] [Related]
38. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
Br J Rheumatol; 1993 Mar; 32 Suppl 1():65-71. PubMed ID: 8448642
[TBL] [Abstract][Full Text] [Related]
39. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
40. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
